Richard T. Kenney

Insider Reports History

Entity
Individual
Location
C/O Immune Design Corp., 1616 Eastlake Ave. E, Suite 310, Seattle, WA
Signature
/s/ John Harry Cross III, power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard T. Kenney:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sonnet BioTherapeutics Holdings, Inc. Chief Medical Officer Common Stock 1.37K $962 $0.70 Dec 11, 2023 Direct

Insider Reports Filed by Richard T. Kenney

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SONN Sonnet BioTherapeutics Holdings, Inc. Dec 11, 2023 1 $0 4 Dec 5, 2024 Chief Medical Officer
SONN Sonnet BioTherapeutics Holdings, Inc. Jan 7, 2023 2 $0 4 Feb 17, 2023 Chief Medical Officer
SONN Sonnet BioTherapeutics Holdings, Inc. Dec 14, 2022 1 $0 4 Dec 22, 2022 Chief Medical Officer
SONN Sonnet BioTherapeutics Holdings, Inc. Jun 9, 2021 1 $23.1K 4 Jun 9, 2021 Chief Medical Officer
SONN Sonnet BioTherapeutics Holdings, Inc. May 19, 2021 1 $15.5K 4 May 20, 2021 Chief Medical Officer